![]() |
Adherence in HIV Disease: How One Person Keeps on Track
|
![]() |
Fast and Easy HIV Testing
|
![]() |
Communicating HIV Treatment Side Effects with Your Doctor
|
![]() |
Making The Decision To Start HIV Therapy
|
![]() |
HIV and Anemia: An Overlooked Danger
|
![]() |
Sticking to It: An HIV Patient Discusses Adherence
|
![]() |
HIV Medicines and Cholesterol: Is There a Link?
|
![]() |
Update on Lipodystrophy in HIV
|
![]() |
Dealing with Wasting in HIV Disease
|
![]() |
One Man Faces the Challenges of Cholesterol and HIV
|
![]() |
HIV and Anemia: One Patient's Story
|
![]() |
Lipodystrophy in HIV Disease
|
![]() |
Why Adherence Matters for Antiretrovirals
|
Treatment of pregnant women with HIV is particularly important in that anti-retroviral therapy has been shown to reduce transmission to the infant by 65%.
Alternative treatments for AIDS can be grouped into two categories: those intended to help the immune system
At the present time, there is no cure for AIDS.
Treatment stresses aggressive combination drug therapy for those patients with access to the expensive medications and who tolerate them adequately. The use of these multi-drug therapies has significantly reduced the numbers of deaths, in this country, resulting from AIDS. The data is still inconclusive, but the potential exists to possibly prolong life indefinitely using these and other drug therapies to boost the immune system, keep the virus from replicating, and ward off opportunistic infections and malignancies.
Prognosis after the latency period depends on the patient's specific symptoms and the organ systems affected by the disease. Patients with AIDS-related lymphomas of the central nervous system die within two to three months of diagnosis; those with systemic lymphomas may survive for eight to ten months.
As of 2001, there is no vaccine effective against AIDS. Several vaccines are currently being investigated, however, both to prevent initial HIV infection and as a therapeutic treatment to prevent HIV from progressing to full-blown AIDS.
In the meantime, there are many things that can be done to prevent the spread of AIDS:
Early HIV Infection Guideline Panel. Evaluation and Management of Early HIV Infection. Rockville, MD: U.S. Department of Health and Human Services, Agency for Health Care Policy and Research, 1994.
Huber, Jeffrey T. Dictionary of AIDS-Related Terminology. New York and London: Neal-Schuman Publishers, Inc., 1993.
"Infectious Diseases: Human Immunodeficiency Virus (HIV)." In Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs. Ed. Tricia Lacy Gomella, et al. Norwalk, CT: Appleton & Lange, 1994.
Katz, Mitchell H., and Harry Hollander. "HIV Infection." In Current Medical Diagnosis & Treatment. Ed. Lawrence M. Tierney Jr., et al. Stamford, CT: Appleton & Lange, 1998.
McFarland, Elizabeth J. "Human Immunodeficiency Virus (HIV) Infections: Acquired Immunodeficiency Syndrome (AIDS)." In Current Pediatric Diagnosis & Treatment. Ed. William W. Hay Jr., et al. Stamford, CT: Appleton & Lange, 1997.
So, Peter, and Livette Johnson. "Acquired Immune Deficiency Syndrome (AIDS)." In Conn's Current Therapy. Ed. Robert E. Rakel. Philadelphia: W. B. Saunders Company, 1997.
Xiao, X., L. Wu, T. S. Stantchev, Y. R. Feng, S. Ugolini, H. Chen, Z. Shen, J. L. Riley, C. C. Broder, Q. J. Sattentau, and D. S. Dimitrov. "Constitutive cell surface association between CD4 and CCR5." Proceedings of the National Academy of Sciences of the United States of America. (June 1999): 7496-7501.
Gay Men's Health Crisis, Inc., 129 West 20th Street, New York, NY 10011-0022. (212) 807-6655.
National AIDS Hot Line. (800) 342-AIDS (English). (800) 344-SIDA (Spanish). (800) AIDS-TTY (hearing-impaired).
"FDA Approved Drugs for HIV Infection and AIDS-Related Conditions." HIV/AIDS Treatment Information Service website. January 2001. <http://hivatis.org>.
Rebecca J. Frey
|
|
Author Info: Rebecca J. Frey, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Medicine, 2002 |